Swiss National Bank Compugen LTD Transaction History

Swiss National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.57 - $3.33 $313,372 - $664,668	-199,600 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.76 - $4.64 $45,264 - $76,096	16,400 Added 8.95%	199,600 $643,000
Q2 2021 Aug 06, 2021	SELL	$6.87 - $9.16 $37,785 - $50,380	-5,500 Reduced 2.91%	183,200 $1.52 Million
Q4 2020 Feb 05, 2021	BUY	$12.07 - $17.95 $98,974 - $147,190	8,200 Added 4.54%	188,700 $2.29 Million
Q3 2020 Nov 09, 2020	BUY	$14.16 - $19.45 $145,848 - $200,335	10,300 Added 6.05%	180,500 $2.93 Million
Q2 2020 Aug 05, 2020	BUY	$6.97 - $17.12 $1.19 Million - $2.91 Million	170,200 New	170,200 $2.56 Million

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.